(VNDA) Vanda Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Vanda Pharmaceuticals | (VNDA) share price targets
Complete technical analysis of Vanda Pharmaceuticals (VNDA) by charts plus indicators, forecast predictions and share price targets for Vanda Pharmaceuticals (VNDA)
Vanda Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2025-02-03 View latest technical analysis
10 day averaged volume of Vanda Pharmaceuticals is 660380
| Date | Daily Closing Price | Open | High | Low | Volume |
| 03 Mon Feb 2025 | 4.31 | 4.35 | 4.35 | 4.22 | 0.863 times |
| 31 Fri Jan 2025 | 4.41 | 4.59 | 4.60 | 4.38 | 0.77 times |
| 30 Thu Jan 2025 | 4.58 | 4.60 | 4.61 | 4.48 | 0.574 times |
| 29 Wed Jan 2025 | 4.53 | 4.43 | 4.59 | 4.40 | 0.754 times |
| 28 Tue Jan 2025 | 4.44 | 4.42 | 4.51 | 4.37 | 0.84 times |
| 27 Mon Jan 2025 | 4.45 | 4.48 | 4.58 | 4.38 | 0.893 times |
| 24 Fri Jan 2025 | 4.40 | 4.39 | 4.41 | 4.33 | 0.958 times |
| 23 Thu Jan 2025 | 4.42 | 4.33 | 4.44 | 4.30 | 0.745 times |
| 22 Wed Jan 2025 | 4.35 | 4.51 | 4.55 | 4.35 | 3.226 times |
| 21 Tue Jan 2025 | 4.51 | 4.40 | 4.53 | 4.39 | 0.741 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 4.4, but if it comes above 4.4, then a intra day buy could be more profitable.
If you take a sell trade below 4.4, then use 4.4 as stoploss and 4.2 as target. However if you take a buy trade in stock , then use 4.4 as stoploss and 4.48 as target.
Share price targets for Vanda Pharmaceuticals (VNDA)
| Target Type | Value |
| Downside Target | 4.22 |
| Upside Target | 4.45 |
| Upside Target | 4.55 |
| Upside Target | 4.60 |
| Upside Target | 4.61 |
| Upside Target | 4.62 |
| Upside Target | 4.95 |
| Upside Target | 5.30 |
| Upside Target | 5.55 |
Intraday share price targets for Vanda Pharmaceuticals (VNDA)
| Target Type | Value |
| Downside Intraday Target | 4.24 |
| Downside Intraday Target | 4.16 |
| Upside Intraday Target | 4.37 |
| Upside Intraday Target | 4.42 |
| Downside Intraday Target | 4.29 |
Weekly technical analysis of Vanda Pharmaceuticals (VNDA)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 03 Mon Feb 2025 | 4.31 | 4.35 | 4.35 | 4.22 | 0.225 times |
| 31 Fri Jan 2025 | 4.41 | 4.48 | 4.61 | 4.37 | 0.676 times |
| 24 Fri Jan 2025 | 4.40 | 4.40 | 4.55 | 4.30 | 11.342 times |
| 17 Fri Jan 2025 | 4.36 | 4.45 | 4.45 | 4.30 | 0.142 times |
| 17 Fri Jan 2025 | 4.36 | 4.60 | 4.60 | 4.30 | 2.038 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Vanda Pharmaceuticals (VNDA)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 03 Mon Feb 2025 | 4.31 | 4.35 | 4.35 | 4.22 | 0.045 times |
| 31 Fri Jan 2025 | 4.41 | 4.85 | 4.95 | 4.30 | 1.174 times |
| 31 Tue Dec 2024 | 4.79 | 4.87 | 4.95 | 4.45 | 0.823 times |
| 26 Tue Nov 2024 | 4.98 | 4.66 | 5.55 | 4.62 | 0.928 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Vanda Pharmaceuticals (VNDA)
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Vanda Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Vanda Pharmaceuticals in short term but the buy signal is initial and weak.
Vanda Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Vanda Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Vanda Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.41 and Vanda Pharmaceuticals (VNDA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Vanda Pharmaceuticals (VNDA) stock. Volume based technical analysis of Vanda Pharmaceuticals (VNDA) stock is negative.
Vanda Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Vanda Pharmaceuticals ( (VNDA) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Vanda Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Vanda Pharmaceuticals in short term but the buy signal is initial and weak.
Vanda Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Vanda Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Vanda Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.41 and Vanda Pharmaceuticals (VNDA) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Vanda Pharmaceuticals (VNDA) stock. Volume based technical analysis of Vanda Pharmaceuticals (VNDA) stock is negative.
Vanda Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.